AVXL
Anavex Life Sciences Corp
1.60$
-2.7%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 100.0% | 99.8% | 100.0% | 100.0% | 100.0% | 100.0% | 98.8% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 97.8% | 97.1% | 96.3% | 98.0% | 97.5% | 97.4% | 98.8% | 98.8% | 98.8% | 99.1% | 99.0% | 98.5% | |
| 97.8% | 97.1% | 96.3% | 98.0% | 97.5% | 97.4% | 98.8% | 98.8% | 98.8% | 99.1% | 99.0% | 98.5% | |
| 1.8% | 2.4% | 2.6% | 1.2% | 1.8% | 2.1% | 0.6% | 0.8% | 0.8% | 0.6% | 0.7% | 0.8% | |
| 8.1% | 8.4% | 6.6% | 8.3% | 11.3% | 10.6% | 14.8% | 11.2% | 8.6% | 4.8% | 5.5% | 6.4% | |
| 8.1% | 8.4% | 6.6% | 8.3% | 11.3% | 10.6% | 14.8% | 11.2% | 8.6% | 4.8% | 5.5% | 6.4% | |
| – | – | 0.6% | -0.6% | – | – | – | – | – | – | – | – | |
| 2.8% | 2.9% | 2.6% | 2.5% | 7.1% | 3.7% | 6.0% | 6.6% | 4.1% | 2.0% | 2.0% | 3.0% | |
| 91.9% | 91.6% | 93.4% | 91.7% | 88.7% | 89.4% | 85.2% | 88.8% | 91.4% | 95.2% | 94.5% | 93.6% | |
| -189.8% | -203.7% | -215.7% | -229.2% | -247.9% | -280.7% | -306.8% | -363.8% | -368.4% | -291.9% | -305.6% | -321.0% | |
| 51.7% | 55.4% | 57.0% | 59.7% | 62.0% | 68.4% | 72.6% | 83.4% | 82.7% | 66.9% | 72.0% | 76.1% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.